| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.04 | 0.6 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |